Mild hypothermia is increasingly touted as a low risk clinical measure in brain protection. This article reviews potential adverse effects of mild hypothermia by organ system and suggests a risk assessment framework for clinical decision making.
Mild hypothermia (33"-35°C) has been shown to be protective in the laboratory settings of incomplete global ischemia and focal cerebral ischemia. Three human studies suggest that prolonged extraoperative mild hypothermia is associated with better neurologic outcome after head injury (1-3). Mild hypothermia has been proposed for clinical use as an adjunct for achieving protection from cerebral ischemia (43). Mild intraoperative hypothermia is currently used for brain protection during aneurysm clipping at several major centers.
The following discussion reviews complications of hypothermic therapy and relates their risk to the potential benefits of mild hypothermia. Induction and maintenance of mild hypothermia are occasionally associated with unintentional further temperature reduction. Accordingly, literature dealing with temperature reduction to 30°C is reviewed.
CIRCULATORY EFFECTS
The circulatory effects of hypothermia include increased peripheral vascular resistance and cardiac afterload (6,7). As cooling proceeds, fluid leaves the vascular space, resulting in mild increases in hematocrit and blood viscosity (8). Hemoconcentration and low microcirculatory flow contribute to the known increase in blood viscosity of 4964% for each 1°C in temperature reduction (8). Coldinduced diuresis caused -by suppression of antidiuretic hormone (ADH) and shunting of peripheral blood volume centrally leads to further depletion of intravascular volume. The hypothermic patient may therefore be at greater risk for hypovolemia when compared to a normothermic individual, particularly once rewarming is started. 
CARDIAC EFFECTS

